PubMed COVID-19 Clinical Care
35571 - 35580 of 57555 results found
Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study
Description
CONCLUSION: In a real-world setting, remdesivir proved to be a safe and well-tolerated treatment for moderate-to-severe COVID-19. In patients receiving remdesivir less than 3 or 5 days from the onset of SARS-CoV-2 symptoms, mortality and the need for
Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants
Description
No abstract
Temporal trends in personal protective equipment (PPE) debris during the COVID-19 pandemic in Çanakkale (Turkey)
Description
This study examines trends in PPE (masks, gloves) and disinfecting wipes over three years of the pandemic. The densities of discarded masks, wet wipes, and gloves (personal protective equipment: PPE), were quantified on the streets of Canakkale
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
Description
SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal transmembrane protein, can serve as an alternative receptor for SARS